Sabo, Ana

Link to this page

Authority KeyName Variants
orcid::0000-0002-2858-6723
  • Sabo, Ana (4)
Projects

Author's Bibliography

Analysis of antibiotic consumption for treating respiratory tract infections in children and compliance with the national clinical guidelines

Lakić, Dragana; Tadić, Ivana; Odalović, Marina; Tasić, Ljiljana; Sabo, Ana; Mećava, Aleksandra

(Društvo lekara Vojvodine Srpskog lekarskog društva, Novi Sad, 2014)

TY  - JOUR
AU  - Lakić, Dragana
AU  - Tadić, Ivana
AU  - Odalović, Marina
AU  - Tasić, Ljiljana
AU  - Sabo, Ana
AU  - Mećava, Aleksandra
PY  - 2014
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/2244
AB  - Introduction. Respiratory infections are the most common infections in children. The aims of the study were to analyze the use of antibiotics for respiratory infections in the period 2008 - 2010 in children's population in region of Niš and to estimate the rational use of antibiotics in relation to the recommendations of the National Guidelines for physicians in primary care. Material and methods. Data source was a Pharmacy Niš database. Antibiotics prescriptions were selected for the following diagnoses: H65-H75 (acute otitis media, mastoiditis), J01 (acute sinusitis), J02-J03 (tonsillopharyngitis), J12-J18 (community acquired pneumonia), J20 (acute bronchitis), J32 (chronic sinusitis), J42 (chronic bronchitis). Antibiotic consumption was expressed in defined daily dose/1000 inhabitants/day. Results. The most widely prescribed antibiotic for the treatment of upper respiratory tract infections in children during the three years was amoxicillin (34.63; 32.50 and 31.00 defined daily dose/1000 inhabitants/day in 2008, 2009 and 2010, respectively). In the treatment of infections of the middle ear and mastoid, the combination of amoxicillin and clavulanic acid, was the most prescribed antibiotics (60% of total consumption of antibiotics for this indication). Azithromycin was the most widely prescribed antibiotic for the treatment of lower respiratory tract infections in children during the observed period (6.92; 8.20 and 7.18 defined daily dose/1000 inhabitans/day in 2008, 2009 and 2010, respectively). Conclusion. Recommendations of national guidelines are not complied with the treatment of upper and lower respiratory infections in the children population in region of Niš. This could be a sign of potentially irrational use of antibiotics that need to be further examined. Education of physicians can influence irrational use of antibiotics.
AB  - Uvod. Infekcije respiratornog sistema predstavljaju najčešće infekcije kod dece. Ciljevi ovog rada jesu analiza potrošnje antibiotika u lečenju infekcija gornjih i donjih respiratornih puteva kod dece u Nišavskom okrugu i procena racionalnosti upotrebe antibiotika u odnosu na preporuke Nacionalnog vodiča za lekare u primarnoj zdravstvenoj zaštiti. Materijal i metode. Kao izvor podataka korišćena je baza podataka Apoteke Niš za period 2008-2010. godine. Selektovani su svi izdati recepti antibiotika propisani deci starosti 0-19 godina za terapiju infekcija respiratornog trakta uključujući infekcije srednjeg uva ((H65-H75 (akutni otitis media i mastoiditis), J01 (akutni sinuzitis), J02-J03 (tonzilofaringitis), J32 (hronični sinuzitis) (J12-J18 (blaga do umerena pneumonija izazvana vanbolničkim uzročnikom), J20 (akutni bronhitis), J42 (hronični bronhitis)). Potrošnja je izražena u definitivnoj dnevnoj dozi/1 000 stanovnika/dan. Rezultati. Najpropisivaniji antibiotik za terapiju infekcija gornjeg respiratornog trakta kod dece u posmatranom periodu bio je amoksicilin (34,63; 32,5 i 31 definitivnoj dnevnoj dozi/1 000 stanovnika/ dan tokom 2008, 2009. i 2010. godine). Za terapiju infekcije srednjeg uva i mastoidnog nastavka najčešće je korišćena kombinacija amoksicilina i klavulanske kiseline (60% ukupne potrošnje svih antibiotika za ovu indikaciju). Azitromicin je bio najpropisivaniji antibiotik za terapiju infekcija donjeg respiratornog trakta kod dece tokom posmatranog perioda (6,92; 8,2 i 7,18 definitivnoj dnevnoj dozi/1 000 stanovnika/dan tokom 2008, 2009. i 2010. godine). Zaključak. Preporuke nacionalnih vodiča nisu poštovane ni u slučaju terapije gornjih ni donjih respiratornih infekcija kod dece u Nišavskom regionu. To može biti znak potencijalno neracionalne upotrebe antibiotika koju je potrebno dodatno istražiti. Dodatna edukacija lekara mogla bi uticati na smanjivanje neracionalne upotrebe antibiotika.
PB  - Društvo lekara Vojvodine Srpskog lekarskog društva, Novi Sad
T2  - Medicinski pregled
T1  - Analysis of antibiotic consumption for treating respiratory tract infections in children and compliance with the national clinical guidelines
T1  - Analiza potrošnje antibiotika za lečenje infekcija respiratornog trakta u dečjoj populaciji i usklađenosti sa nacionalnim vodičima dobre kliničke prakse
VL  - 67
IS  - 9-10
SP  - 282
EP  - 289
DO  - 10.2298/MPNS1410282L
ER  - 
@article{
author = "Lakić, Dragana and Tadić, Ivana and Odalović, Marina and Tasić, Ljiljana and Sabo, Ana and Mećava, Aleksandra",
year = "2014",
abstract = "Introduction. Respiratory infections are the most common infections in children. The aims of the study were to analyze the use of antibiotics for respiratory infections in the period 2008 - 2010 in children's population in region of Niš and to estimate the rational use of antibiotics in relation to the recommendations of the National Guidelines for physicians in primary care. Material and methods. Data source was a Pharmacy Niš database. Antibiotics prescriptions were selected for the following diagnoses: H65-H75 (acute otitis media, mastoiditis), J01 (acute sinusitis), J02-J03 (tonsillopharyngitis), J12-J18 (community acquired pneumonia), J20 (acute bronchitis), J32 (chronic sinusitis), J42 (chronic bronchitis). Antibiotic consumption was expressed in defined daily dose/1000 inhabitants/day. Results. The most widely prescribed antibiotic for the treatment of upper respiratory tract infections in children during the three years was amoxicillin (34.63; 32.50 and 31.00 defined daily dose/1000 inhabitants/day in 2008, 2009 and 2010, respectively). In the treatment of infections of the middle ear and mastoid, the combination of amoxicillin and clavulanic acid, was the most prescribed antibiotics (60% of total consumption of antibiotics for this indication). Azithromycin was the most widely prescribed antibiotic for the treatment of lower respiratory tract infections in children during the observed period (6.92; 8.20 and 7.18 defined daily dose/1000 inhabitans/day in 2008, 2009 and 2010, respectively). Conclusion. Recommendations of national guidelines are not complied with the treatment of upper and lower respiratory infections in the children population in region of Niš. This could be a sign of potentially irrational use of antibiotics that need to be further examined. Education of physicians can influence irrational use of antibiotics., Uvod. Infekcije respiratornog sistema predstavljaju najčešće infekcije kod dece. Ciljevi ovog rada jesu analiza potrošnje antibiotika u lečenju infekcija gornjih i donjih respiratornih puteva kod dece u Nišavskom okrugu i procena racionalnosti upotrebe antibiotika u odnosu na preporuke Nacionalnog vodiča za lekare u primarnoj zdravstvenoj zaštiti. Materijal i metode. Kao izvor podataka korišćena je baza podataka Apoteke Niš za period 2008-2010. godine. Selektovani su svi izdati recepti antibiotika propisani deci starosti 0-19 godina za terapiju infekcija respiratornog trakta uključujući infekcije srednjeg uva ((H65-H75 (akutni otitis media i mastoiditis), J01 (akutni sinuzitis), J02-J03 (tonzilofaringitis), J32 (hronični sinuzitis) (J12-J18 (blaga do umerena pneumonija izazvana vanbolničkim uzročnikom), J20 (akutni bronhitis), J42 (hronični bronhitis)). Potrošnja je izražena u definitivnoj dnevnoj dozi/1 000 stanovnika/dan. Rezultati. Najpropisivaniji antibiotik za terapiju infekcija gornjeg respiratornog trakta kod dece u posmatranom periodu bio je amoksicilin (34,63; 32,5 i 31 definitivnoj dnevnoj dozi/1 000 stanovnika/ dan tokom 2008, 2009. i 2010. godine). Za terapiju infekcije srednjeg uva i mastoidnog nastavka najčešće je korišćena kombinacija amoksicilina i klavulanske kiseline (60% ukupne potrošnje svih antibiotika za ovu indikaciju). Azitromicin je bio najpropisivaniji antibiotik za terapiju infekcija donjeg respiratornog trakta kod dece tokom posmatranog perioda (6,92; 8,2 i 7,18 definitivnoj dnevnoj dozi/1 000 stanovnika/dan tokom 2008, 2009. i 2010. godine). Zaključak. Preporuke nacionalnih vodiča nisu poštovane ni u slučaju terapije gornjih ni donjih respiratornih infekcija kod dece u Nišavskom regionu. To može biti znak potencijalno neracionalne upotrebe antibiotika koju je potrebno dodatno istražiti. Dodatna edukacija lekara mogla bi uticati na smanjivanje neracionalne upotrebe antibiotika.",
publisher = "Društvo lekara Vojvodine Srpskog lekarskog društva, Novi Sad",
journal = "Medicinski pregled",
title = "Analysis of antibiotic consumption for treating respiratory tract infections in children and compliance with the national clinical guidelines, Analiza potrošnje antibiotika za lečenje infekcija respiratornog trakta u dečjoj populaciji i usklađenosti sa nacionalnim vodičima dobre kliničke prakse",
volume = "67",
number = "9-10",
pages = "282-289",
doi = "10.2298/MPNS1410282L"
}
Lakić, D., Tadić, I., Odalović, M., Tasić, L., Sabo, A.,& Mećava, A.. (2014). Analysis of antibiotic consumption for treating respiratory tract infections in children and compliance with the national clinical guidelines. in Medicinski pregled
Društvo lekara Vojvodine Srpskog lekarskog društva, Novi Sad., 67(9-10), 282-289.
https://doi.org/10.2298/MPNS1410282L
Lakić D, Tadić I, Odalović M, Tasić L, Sabo A, Mećava A. Analysis of antibiotic consumption for treating respiratory tract infections in children and compliance with the national clinical guidelines. in Medicinski pregled. 2014;67(9-10):282-289.
doi:10.2298/MPNS1410282L .
Lakić, Dragana, Tadić, Ivana, Odalović, Marina, Tasić, Ljiljana, Sabo, Ana, Mećava, Aleksandra, "Analysis of antibiotic consumption for treating respiratory tract infections in children and compliance with the national clinical guidelines" in Medicinski pregled, 67, no. 9-10 (2014):282-289,
https://doi.org/10.2298/MPNS1410282L . .
4
8

Predictors of the use of medications before and during pregnancy

Odalović, Marina; Vezmar-Kovačević, Sandra; Nordeng, Hedvig; Ilić, Katarina; Sabo, Ana; Tasić, Ljiljana

(Springer, Dordrecht, 2013)

TY  - JOUR
AU  - Odalović, Marina
AU  - Vezmar-Kovačević, Sandra
AU  - Nordeng, Hedvig
AU  - Ilić, Katarina
AU  - Sabo, Ana
AU  - Tasić, Ljiljana
PY  - 2013
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/1987
AB  - Background Drug use in pregnancy is often reason of concern for mothers and their physicians. However, only few studies investigated predictors of drug use in pregnancy. Objectives To examine maternal characteristics as predictors of medication use in the 6 months before pregnancy and during the first 6 months of pregnancy. To examine whether prescription and over-the-counter (OTC) medication use in the 6 months before pregnancy had an impact on medication use in pregnancy. Setting Six maternity care units and five community pharmacies. Method Data were collected using a specially designed self-reported questionnaire during the period March 2009-March 2010. Logistic regression was used to identify factors associated with medication use. Main outcome measure Adjusted odds ratios (aOR) and 95 % confidence intervals (CI) were used as association measures. Results A total of 236 women were included in the analysis. After controlling for maternal characteristics, parity of more than one was associated with lower prescription medication use in pregnancy (aOR 0.46; 95 % CI 0.22-0.93), higher household income with higher OTC medication use before pregnancy (aOR 3.13; 95 % CI 1.22-8.00), and miscarriage with higher C and D Food and Drug Administration (FDA) risk category medication use in pregnancy (aOR 3.65; 95 % CI 1.30-10.25). Prescription medication use before pregnancy was associated with higher prescription medication use in pregnancy (aOR 2.49; 95 % CI 1.12-5.52), OTC medication use before pregnancy with higher OTC medication use in pregnancy (aOR 35.95; 95 % CI 7.95-162.49), and C and D FDA risk category medication use before pregnancy with the same category medication use in pregnancy (aOR 3.54; 95 % CI 1.23-10.17). Conclusion Different maternal characteristics were shown as predictors of medication use before and during pregnancy. However, medication use before pregnancy was shown as the most important predicting factor for the medication use in pregnancy.
PB  - Springer, Dordrecht
T2  - International Journal of Clinical Pharmacy
T1  - Predictors of the use of medications before and during pregnancy
VL  - 35
IS  - 3
SP  - 408
EP  - 416
DO  - 10.1007/s11096-013-9750-7
ER  - 
@article{
author = "Odalović, Marina and Vezmar-Kovačević, Sandra and Nordeng, Hedvig and Ilić, Katarina and Sabo, Ana and Tasić, Ljiljana",
year = "2013",
abstract = "Background Drug use in pregnancy is often reason of concern for mothers and their physicians. However, only few studies investigated predictors of drug use in pregnancy. Objectives To examine maternal characteristics as predictors of medication use in the 6 months before pregnancy and during the first 6 months of pregnancy. To examine whether prescription and over-the-counter (OTC) medication use in the 6 months before pregnancy had an impact on medication use in pregnancy. Setting Six maternity care units and five community pharmacies. Method Data were collected using a specially designed self-reported questionnaire during the period March 2009-March 2010. Logistic regression was used to identify factors associated with medication use. Main outcome measure Adjusted odds ratios (aOR) and 95 % confidence intervals (CI) were used as association measures. Results A total of 236 women were included in the analysis. After controlling for maternal characteristics, parity of more than one was associated with lower prescription medication use in pregnancy (aOR 0.46; 95 % CI 0.22-0.93), higher household income with higher OTC medication use before pregnancy (aOR 3.13; 95 % CI 1.22-8.00), and miscarriage with higher C and D Food and Drug Administration (FDA) risk category medication use in pregnancy (aOR 3.65; 95 % CI 1.30-10.25). Prescription medication use before pregnancy was associated with higher prescription medication use in pregnancy (aOR 2.49; 95 % CI 1.12-5.52), OTC medication use before pregnancy with higher OTC medication use in pregnancy (aOR 35.95; 95 % CI 7.95-162.49), and C and D FDA risk category medication use before pregnancy with the same category medication use in pregnancy (aOR 3.54; 95 % CI 1.23-10.17). Conclusion Different maternal characteristics were shown as predictors of medication use before and during pregnancy. However, medication use before pregnancy was shown as the most important predicting factor for the medication use in pregnancy.",
publisher = "Springer, Dordrecht",
journal = "International Journal of Clinical Pharmacy",
title = "Predictors of the use of medications before and during pregnancy",
volume = "35",
number = "3",
pages = "408-416",
doi = "10.1007/s11096-013-9750-7"
}
Odalović, M., Vezmar-Kovačević, S., Nordeng, H., Ilić, K., Sabo, A.,& Tasić, L.. (2013). Predictors of the use of medications before and during pregnancy. in International Journal of Clinical Pharmacy
Springer, Dordrecht., 35(3), 408-416.
https://doi.org/10.1007/s11096-013-9750-7
Odalović M, Vezmar-Kovačević S, Nordeng H, Ilić K, Sabo A, Tasić L. Predictors of the use of medications before and during pregnancy. in International Journal of Clinical Pharmacy. 2013;35(3):408-416.
doi:10.1007/s11096-013-9750-7 .
Odalović, Marina, Vezmar-Kovačević, Sandra, Nordeng, Hedvig, Ilić, Katarina, Sabo, Ana, Tasić, Ljiljana, "Predictors of the use of medications before and during pregnancy" in International Journal of Clinical Pharmacy, 35, no. 3 (2013):408-416,
https://doi.org/10.1007/s11096-013-9750-7 . .
7
19
18
20

Upotreba antibiotika u terapiji upale srednjeg uha kod dece

Odalović, Marina; Tadić, Ivana; Lakić, Dragana; Tasić, Ljiljana; Sabo, Ana; Nestorović, Svetlana

(Beograd: Farmaceutski fakultet Univerziteta u Beogradu, 2012)

TY  - CONF
AU  - Odalović, Marina
AU  - Tadić, Ivana
AU  - Lakić, Dragana
AU  - Tasić, Ljiljana
AU  - Sabo, Ana
AU  - Nestorović, Svetlana
PY  - 2012
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4232
AB  - Uvod: Upala srednjeg uha je veoma česta infekcija tokom detinjstva i nekada zahteva antibiotsku terapiju. 
Ciljevi: (i) Istražiti oralnu upotrebu antibiotika u terapiji upale srednjeg uha kod dece uzrasta 5-9 godina. (ii) Proceniti doslednost i poštovanje preporuka Nacionalnog vodiča za primarnu zdravstvenu zaštitu i terapiju upale srednjeg uha.   
Metode: Retrospektivna studija je sprovedena tokom perioda 2008-2010. godine u populaciji dece Nišavskog regiona starosti od 5-9 godina (17.683 dece). Kao izvor informacija korišćena je baza podataka o izdatim antibioticima na lekarski recept Apoteke Niš. Antibiotici su klasifikovani prema anatomsko-terapijsko-hemijskoj klasifikaciji Svetske zdravstvene organizacije. Definisana dnevna doza na hiljadu stanovnika dnevno (DDD/1000 stanovnika/dan) korišćena je u svrhu iskazivanja potrošnje antibiotika. Procenjivano je pridržavanje lekara sa Nacionalnog vodiča za propisivanje antibiotika (prva terapijska linija: amoksicilin; druga terapijska linija: amoksicilin sa klavulanskom kiselinom).
Rezultati: Najviše korišćen antibiotik u oralnoj terapiji upale srednjeg uha kod dece starosti 5-9 godina tokom perioda 2008-2010 bio je amoksicilin sa klavulanskom kiselinom (0,8970; 0,8312 i 0,9475 DDD/1000 stanovnika/dan, respektivno). Ostali antibiotici su korišćeni znatno manje, amoksicilin (0,0744; 0,0555 i 0,0550 DDD/1000 stanovnika/dan, respektivno), cefprozil (0,0632; 0,0641 i 0,0488 DDD/1000 stanovnika/dan, respektivno) i cefiksim (0,0418; 0,0542 i 0,0597 DDD/1000 stanovnika/dan, respektivno). 
Zaključak: Antibiotici koje preporučuje Nacionalni vodič se dominantno koriste u oralnoj terapiji upale srednjeg uha kod dece.  Međutim, amoksicilin (prva terapijska linija) korišćen je mnogo manje od amoksicilina sa klavulanskom kiselinom (druga terapijska linija). Dalja istraživanja upotrebe antibiotika kod dece u Srbiji su neophodna, kao i edukacija pedijatara/propisivače.
PB  - Beograd: Farmaceutski fakultet Univerziteta u Beogradu
C3  - Zbornik radova simpozijuma "Zdravstveni ishodi & socijalna farmacija" / II naučni simpozijum Farmaceutskog fakulteta, 14. septembar 2012
T1  - Upotreba antibiotika u terapiji upale srednjeg uha kod dece
SP  - 106
EP  - 107
UR  - https://hdl.handle.net/21.15107/rcub_farfar_4232
ER  - 
@conference{
author = "Odalović, Marina and Tadić, Ivana and Lakić, Dragana and Tasić, Ljiljana and Sabo, Ana and Nestorović, Svetlana",
year = "2012",
abstract = "Uvod: Upala srednjeg uha je veoma česta infekcija tokom detinjstva i nekada zahteva antibiotsku terapiju. 
Ciljevi: (i) Istražiti oralnu upotrebu antibiotika u terapiji upale srednjeg uha kod dece uzrasta 5-9 godina. (ii) Proceniti doslednost i poštovanje preporuka Nacionalnog vodiča za primarnu zdravstvenu zaštitu i terapiju upale srednjeg uha.   
Metode: Retrospektivna studija je sprovedena tokom perioda 2008-2010. godine u populaciji dece Nišavskog regiona starosti od 5-9 godina (17.683 dece). Kao izvor informacija korišćena je baza podataka o izdatim antibioticima na lekarski recept Apoteke Niš. Antibiotici su klasifikovani prema anatomsko-terapijsko-hemijskoj klasifikaciji Svetske zdravstvene organizacije. Definisana dnevna doza na hiljadu stanovnika dnevno (DDD/1000 stanovnika/dan) korišćena je u svrhu iskazivanja potrošnje antibiotika. Procenjivano je pridržavanje lekara sa Nacionalnog vodiča za propisivanje antibiotika (prva terapijska linija: amoksicilin; druga terapijska linija: amoksicilin sa klavulanskom kiselinom).
Rezultati: Najviše korišćen antibiotik u oralnoj terapiji upale srednjeg uha kod dece starosti 5-9 godina tokom perioda 2008-2010 bio je amoksicilin sa klavulanskom kiselinom (0,8970; 0,8312 i 0,9475 DDD/1000 stanovnika/dan, respektivno). Ostali antibiotici su korišćeni znatno manje, amoksicilin (0,0744; 0,0555 i 0,0550 DDD/1000 stanovnika/dan, respektivno), cefprozil (0,0632; 0,0641 i 0,0488 DDD/1000 stanovnika/dan, respektivno) i cefiksim (0,0418; 0,0542 i 0,0597 DDD/1000 stanovnika/dan, respektivno). 
Zaključak: Antibiotici koje preporučuje Nacionalni vodič se dominantno koriste u oralnoj terapiji upale srednjeg uha kod dece.  Međutim, amoksicilin (prva terapijska linija) korišćen je mnogo manje od amoksicilina sa klavulanskom kiselinom (druga terapijska linija). Dalja istraživanja upotrebe antibiotika kod dece u Srbiji su neophodna, kao i edukacija pedijatara/propisivače.",
publisher = "Beograd: Farmaceutski fakultet Univerziteta u Beogradu",
journal = "Zbornik radova simpozijuma "Zdravstveni ishodi & socijalna farmacija" / II naučni simpozijum Farmaceutskog fakulteta, 14. septembar 2012",
title = "Upotreba antibiotika u terapiji upale srednjeg uha kod dece",
pages = "106-107",
url = "https://hdl.handle.net/21.15107/rcub_farfar_4232"
}
Odalović, M., Tadić, I., Lakić, D., Tasić, L., Sabo, A.,& Nestorović, S.. (2012). Upotreba antibiotika u terapiji upale srednjeg uha kod dece. in Zbornik radova simpozijuma "Zdravstveni ishodi & socijalna farmacija" / II naučni simpozijum Farmaceutskog fakulteta, 14. septembar 2012
Beograd: Farmaceutski fakultet Univerziteta u Beogradu., 106-107.
https://hdl.handle.net/21.15107/rcub_farfar_4232
Odalović M, Tadić I, Lakić D, Tasić L, Sabo A, Nestorović S. Upotreba antibiotika u terapiji upale srednjeg uha kod dece. in Zbornik radova simpozijuma "Zdravstveni ishodi & socijalna farmacija" / II naučni simpozijum Farmaceutskog fakulteta, 14. septembar 2012. 2012;:106-107.
https://hdl.handle.net/21.15107/rcub_farfar_4232 .
Odalović, Marina, Tadić, Ivana, Lakić, Dragana, Tasić, Ljiljana, Sabo, Ana, Nestorović, Svetlana, "Upotreba antibiotika u terapiji upale srednjeg uha kod dece" in Zbornik radova simpozijuma "Zdravstveni ishodi & socijalna farmacija" / II naučni simpozijum Farmaceutskog fakulteta, 14. septembar 2012 (2012):106-107,
https://hdl.handle.net/21.15107/rcub_farfar_4232 .

Drug use before and during pregnancy in Serbia

Odalović, Marina; Vezmar-Kovačević, Sandra; Ilić, Katarina; Sabo, Ana; Tasić, Ljiljana

(Springer, Dordrecht, 2012)

TY  - JOUR
AU  - Odalović, Marina
AU  - Vezmar-Kovačević, Sandra
AU  - Ilić, Katarina
AU  - Sabo, Ana
AU  - Tasić, Ljiljana
PY  - 2012
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/1636
AB  - Background Observation of drug use patterns during pregnancy is necessary for the recognition of potential bad practices and improvement of safe drug use in pregnancy. Objective To investigate prescription and over the counter drug use among Serbian women in the 6 months before pregnancy and in the first 6 months of pregnancy, and to evaluate the drugs used according to the risk to a fetus. Setting Six maternity care units and five community pharmacies Method A multi-center study was performed in Serbia during the period from March 2009-March 2010. A self-reporting questionnaire was used as a data source. Food and Drug Administration (FDA) risk classification system was used to determine the risk of used drugs for the fetus. Differences between subgroups were assessed using McNemar's test on paired proportions. Main outcome measure Proportion of women exposed to drugs or class of drugs. Results The overall drug exposure was higher in pregnancy (34.7 %) than before pregnancy (29.9 %), p > 0.05, in the cohort of 311 pregnant women. A significantly greater prescription drug use, 19.0 versus 27.3 % of women, p  lt  0.05, and less selfmedication with over the counter drugs in pregnancy, 15.1 versus 8.7 %, p  lt  0.05, were observed. Commonly used drugs were musculoskeletal drugs, analgesics/antipyretics and respiratory system drugs before pregnancy (13.8, 12.5, and 6.4 % of women, respectively), and progestogens, analgesics/antipyretics, and antibiotics for the systemic use in pregnancy (9.0, 7.7, and 7.4 %, respectively). A greater exposure to drugs belonging to the FDA risk category A (3.9 vs. 60.8 %, p  lt  0.05), B (18.0 vs. 19.6 %, p > 0.05), C (10.0 vs. 10.3 %, p > 0.05) and D (2.9 vs. 10.9 %, p  lt  0.05), as well as less exposure to drugs belonging to category X (0.3 vs. 0 %, p > 0.05) were observed in pregnancy. Folic acid was used by 60.8 % of women in pregnancy, and by only 3.9 % before pregnancy. Conclusion Besides higher overall drug use in pregnancy than before pregnancy, particularly the use of progestogens, and, subsequently, D category drugs, less selfmedication with over the counter drugs was observed in pregnancy. Insufficient use of folic acid before pregnancy requires public health service activities.
PB  - Springer, Dordrecht
T2  - International Journal of Clinical Pharmacy
T1  - Drug use before and during pregnancy in Serbia
VL  - 34
IS  - 5
SP  - 719
EP  - 727
DO  - 10.1007/s11096-012-9665-8
ER  - 
@article{
author = "Odalović, Marina and Vezmar-Kovačević, Sandra and Ilić, Katarina and Sabo, Ana and Tasić, Ljiljana",
year = "2012",
abstract = "Background Observation of drug use patterns during pregnancy is necessary for the recognition of potential bad practices and improvement of safe drug use in pregnancy. Objective To investigate prescription and over the counter drug use among Serbian women in the 6 months before pregnancy and in the first 6 months of pregnancy, and to evaluate the drugs used according to the risk to a fetus. Setting Six maternity care units and five community pharmacies Method A multi-center study was performed in Serbia during the period from March 2009-March 2010. A self-reporting questionnaire was used as a data source. Food and Drug Administration (FDA) risk classification system was used to determine the risk of used drugs for the fetus. Differences between subgroups were assessed using McNemar's test on paired proportions. Main outcome measure Proportion of women exposed to drugs or class of drugs. Results The overall drug exposure was higher in pregnancy (34.7 %) than before pregnancy (29.9 %), p > 0.05, in the cohort of 311 pregnant women. A significantly greater prescription drug use, 19.0 versus 27.3 % of women, p  lt  0.05, and less selfmedication with over the counter drugs in pregnancy, 15.1 versus 8.7 %, p  lt  0.05, were observed. Commonly used drugs were musculoskeletal drugs, analgesics/antipyretics and respiratory system drugs before pregnancy (13.8, 12.5, and 6.4 % of women, respectively), and progestogens, analgesics/antipyretics, and antibiotics for the systemic use in pregnancy (9.0, 7.7, and 7.4 %, respectively). A greater exposure to drugs belonging to the FDA risk category A (3.9 vs. 60.8 %, p  lt  0.05), B (18.0 vs. 19.6 %, p > 0.05), C (10.0 vs. 10.3 %, p > 0.05) and D (2.9 vs. 10.9 %, p  lt  0.05), as well as less exposure to drugs belonging to category X (0.3 vs. 0 %, p > 0.05) were observed in pregnancy. Folic acid was used by 60.8 % of women in pregnancy, and by only 3.9 % before pregnancy. Conclusion Besides higher overall drug use in pregnancy than before pregnancy, particularly the use of progestogens, and, subsequently, D category drugs, less selfmedication with over the counter drugs was observed in pregnancy. Insufficient use of folic acid before pregnancy requires public health service activities.",
publisher = "Springer, Dordrecht",
journal = "International Journal of Clinical Pharmacy",
title = "Drug use before and during pregnancy in Serbia",
volume = "34",
number = "5",
pages = "719-727",
doi = "10.1007/s11096-012-9665-8"
}
Odalović, M., Vezmar-Kovačević, S., Ilić, K., Sabo, A.,& Tasić, L.. (2012). Drug use before and during pregnancy in Serbia. in International Journal of Clinical Pharmacy
Springer, Dordrecht., 34(5), 719-727.
https://doi.org/10.1007/s11096-012-9665-8
Odalović M, Vezmar-Kovačević S, Ilić K, Sabo A, Tasić L. Drug use before and during pregnancy in Serbia. in International Journal of Clinical Pharmacy. 2012;34(5):719-727.
doi:10.1007/s11096-012-9665-8 .
Odalović, Marina, Vezmar-Kovačević, Sandra, Ilić, Katarina, Sabo, Ana, Tasić, Ljiljana, "Drug use before and during pregnancy in Serbia" in International Journal of Clinical Pharmacy, 34, no. 5 (2012):719-727,
https://doi.org/10.1007/s11096-012-9665-8 . .
3
20
17
22